Which immunomodulator?
James
D G
DG
Royal Free Hospital, London.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D015704:CD4 Antigens / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D015704:CD4 Antigens; D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D016559:Tacrolimus